Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Introduction
- Scope and Methodology
- Size and Growth of the Market
- Issues and Trends Affecting Market
- Leading Competitors
CHAPTER TWO: INTRODUCTION
- Overview of the Cardiovascular System
- Heart
- Circulatory System
- Cardiac Cycle
- Isovolumic Contraction
- Ventricular Ejection
- Isovolumic Relaxation
- Coronary Circulation
- Cardiac Myocytes
- Contraction
- Calcium Role in Contraction
- Relaxation
- Cardiac Energy Metabolism
- Cardiac Output
- Cardiovascular Disorders
- Angina
- Incidence
- Etiology and Pathophysiology
- Risk Factors
- Arrhythmias
- Incidence
- Etiology and Pathophysiology
- Risk Factors
- Atherosclerosis
- Incidence
- Etiology and Pathophysiology
- Risk Factors
- Congestive Heart Failure
- Incidence
- Etiology and Pathophysiology
- Risk Factors
- Coronary Artery Disease
- Incidence
- Etiology and Pathophysiology
- Risk Factors
- Hypertension
- Incidence
- Etiology and Pathophysiology
- Risk Factors
- Myocardial Infarction
- Incidence
- Etiology and Pathophysiology
- Risk Factors
- Effects of Aging
- Demographics
- Disease Management
CHAPTER THREE: ISSUES AND TRENDS
- Obesity Epidemic and Heart Disease
- Statin use
- Inflammation Reduction
- Unique Drug Combinations
- Hormone Therapy and Cardiovascular Disease Risks
- CAD Risk Factor Differences in Sexes
- Women and Heart Disease
- Otc Statins
- Genetic Research and Warfarin Use
- Future Trends in the Pharmaceutical Arena
CHAPTER FOUR: PRESCRIPTION CARDIAC GLYCOSIDE AND IONTROPIC DRUGS
- Overview of Cardiac Glycosides and Inotropic Drugs
- Description of Products
- Market Size and Growth World Market
- Research and Development
- Competitive Analysis
CHAPTER FIVE: PRESCRIPTION ANTIHYPERTENSIVE DRUGS
- Overview
- Description of Products
- ACE Inhibitors
- Angiotensin II Receptor Antagonists
- Adrenergic Blockers
- Beta Blockers
- Recent Additions
- Calcium Channel Blockers
- Combinations
- New Developments
- Market Size and Growth
- World Market
- Research and Development
- Nebivolol
- CS- 8663
- Volibris
- Atacand Plus
- Clevidipine
- Coreg CR Plus ACE Inhibitor
- Darusentan
- Competitive Analysis
CHAPTER SIX: PRESCRIPTION ANTIARRHYTHMIC DRUGS
- Overview
- Description of Products
- Class I
- Class II
- Class III
- Market Size and Growth
- World Market
- Research and Development
- Tedasamil (Pulzium)
- RSD 1235 (vernakalant)
- Apixaban
- Bay 59-7939
- Dronedarone (Multaq)
- Idraparinux
- Tecadenoson
- Competitive Analysis
CHAPTER SEVEN: VASODILATOR AND PERIPHERAL VASODILATOR DRUGS
- Overview
- Description of Products
- Coronary Vasodilators
- Natriuretic Peptides
- Peripheral Vasodilators
- Recent Developments
- Market Size and Growth
- World Market
- Research and Development
- Competitive Analysis
CHAPTER EIGHT: PRESCRIPTION ANTIHYPERLIPIDEMIC DRUGS
- Overview
- Description of Products
- Bile Acid Sequestrants
- Fibric Acid Derivatives
- HMG-CoA Reductase Inhibitors (Statins)
- Nicotinic Acid
- Market Size and Growth
- World Market
- Research and Development
- LCP-FenoChol
- Synordia
- Acomplia
- Actos
- MK 0524A, MK0524B
- Pravastatin and Fenofibrate Combination
- AGI-`067
- ABT-335
- Apo-I Milano (ETC-216)
- ETC-642
- FM-VP4
- Competitive Analysis
CHAPTER NINE: PRESCRIPTION BLOOD MODIFIER DRUGS
- Overview
- Description of Products
- Anticoagulants
- Antiplatelets
- Thrombolytics
- New Developments
- Market Size and Growth
- World Market
- Research and Development
- Arixtra
- Exanta
- Cangrelor
- (Prasugrel) CS-747
- Integrilin
- Competitive Analysis
CHAPTER TEN: PRESCRIPTION DIURETIC DRUGS
- Overview
- Description of Products
- Carbonic Anhydrase Inhibitors
- Loop
- Potassium-Sparing
- Thiazides
- Market Size and Growth
- World Market
- Research and Development
- Competitive Analysis
CHAPTER ELEVEN: PRESCRIPTION OTHER CARDIOVASCULAR DRUGS
- Overview
- Description of Products
- Market Size and Growth
- World Market
- Research and Development
- Thelin
- Remodulin IV
- Ambrisentan (Letairis)
- Celacade
- Tadalafil
- Tolvaptan
- DITPA
- Competitive Analysis
CHAPTER TWELVE: WORLD MARKET SUMMARY
- Overview
- Total Market Size and Forecast
- Competitor Analysis
CHAPTER THIRTEEN: CORPORATE PROFILES
- Abbott Laboratories
- AStellas Pharma, Inc.
- Astra Zeneca
- Bayer Schering Pharma
- Biovail Corporation
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Daiichi Sankyo Pharmaceuticals
- Eli Lilly and Company
- Genentech, Inc.
- GlaxoSmithKline
- MERCK & COMPANY INC
- Novartis International AG
- Pfizer, Inc.
- Roche
- Sanofi-Aventis
- Takeda Pharmaceuticals
- Emerging Cardiovascular Companies
- Cardiome Pharma Corporation
- Inotek Pharmaceuticals Corporation
APPENDIX: COMPANY DIRECTORY
TABLE OF EXHIBITS
EXECUTIVE SUMMARY
- Table 1-1: Total World Prescription Cardiovascular Drug Market 2004-2011
- Figure 1-1: Total World Prescription Cardiovascular Drug Market 2004-2011
- Table1-2: World Market for Prescription
- Cardiovascular Drugs Revenues and Segments of Participation by Major Areas
of Participation 2006
- Figure 1-2: World Market for Prescription Cardiovascular Drugs Revenues
and Segments of Participation by Major Areas of Participation 2006
CHAPTER TWO: INTRODUCTION
- Table 2-1: U.S. Prevalence, Incidence and Mortality of Selected
Cardiovascular Conditions
CHAPTER FOUR: PRESCRIPTION CARDIAC GLYCOSIDE AND IONTROPIC DRUGS
- Table 4-1: Marketed Cardiac Glycosides and Inotropic Drugs
- Table 4-2: Total World Cardiac Glycoside & Inotropic Drug Market 2004-2011
- Figure 4-1: Total World Cardiac Glycoside & Inotropic Drug Market 2004-2011
- Table 4-3: Cardiac Glycosides and Inotropic Agents in Development
- Table 4-4: Total Global Market for Cardiac Glycoside & Inotropic Drugs,
Revenues and Market Share by Supplier 2006
- Figure 4-2: Total Global Market for Cardiac Glycoside & Inotropic Drugs,
Market Share by Leading Supplier 2006
CHAPTER FIVE: PRESCRIPTION ANTIHYPERTENSIVE DRUGS
- Table 5-1: Marketed ACE Inhibitors
- Table 5-2: Marketed Angiotensin II Receptor Antagonists
- Table 5-3: Marketed Adrenergic and Beta Blockers
- Table 5-4: Marketed Calcium Channel Blockers
- Table 5-5: Marketed Combination and Other Antihypertensives
- Table 5-6: Total World Prescription Antihypertensive Drug Market 2004-2011
- Figure 5-1: Total World Prescription Antihypertensive Drug Market 2004-2011
- Table 5-6: Total World Prescription Antihypertensive Drug Market by Type
2004-2011
- Figure 5-2: Total World Prescription Antihypertensive Drug Market by Type
2006
- Table 5-7: Hypertensive Drugs in Development
- Table 5-8: Total Global Market for Prescription Antihypertensive Drugs,
Revenues and Market Share by Supplier 2006
- Figure 5-9: Total Global Market for Prescription Antihypertensive Drugs,
Market Share by Leading Supplier 2006
CHAPTER SIX: PRESCRIPTION ANTIARRHYTHMIC DRUGS
- Table 6-1: Marketed Antiarrhythmic Drugs
- Table 6-2: Total World Prescription Antiarrhythmic Drug Market 2004-2011
- Figure 6-1: Total World Prescription Antiarrhythmic Drug Market 2004-2011
- Table 6-3: Antiarrhythmic Drugs in Development
- Table 6-4: Total Global Market for Prescription Antiarrhythmic Drugs,
Revenues and Market Share by Supplier 2006
- Figure 6-3: Total Global Market for Prescription Antiarrhythmic Drugs,
Market Share by Leading Supplier 2006
CHAPTER SEVEN: VASODILATOR AND PERIPHERAL VASODILATOR DRUGS
- Table 7-1: Marketed Vasodilator and Peripheral Vasodilator Drugs
- Table 7-2: Total World Vasodilator and Peripheral Vasodilator Drugs Market
2004-2011
- Figure 7-2: Total World Vasodilator and Peripheral Vasodilator Drugs
Market 2004-2011
- Table 7-3: Vasodilator and Peripheral Vasodilator Drugs in Development
- Table 7-4: Total Global Market for Vasodilator and Peripheral Vasodilator
Drugs Revenues and Market Share by Supplier 2006
- Figure 7-4: Total Global Market for Vasodilator and Peripheral Vasodilator
Drugs Market Share by Leading Supplier 2006
CHAPTER EIGHT: PRESCRIPTION ANTIHYPERLIPIDEMIC DRUGS
- Table 8-1: Marketed Antihyperlipidemic Drugs
- Table 8-2: Total World Prescription Antihyperlipidemic Drugs Market
2004-2011
- Figure 8-1: Total World Prescription Antihyperlipidemic Drugs Market
2004-2011
- Table 8-3: Antihyperlipidemic Drugs in Development
- Table 8-4: Total Global Market for Prescription Antihyperlipidemic Drugs
Revenues and Market Share by Supplier 2006
- Figure 8-2: Total Global Market for Prescription Antihyperlipidemic Drugs
Market Share by Leading Supplier 2006
CHAPTER NINE: PRESCRIPTION BLOOD MODIFIER DRUGS
- Table 9-2: Marketed Anticoagulant Drugs
- Table 9-3: Marketed Antiplatelet Drugs
- Table 9-4: Marketed Thrombolytic Drugs
- Table 9-5: Total World Prescription Blood Modifier Drug Market 2004-2011
- Figure 9-1: Total World Prescription Blood Modifier Drug Market 2004-2011
- Table 9-6: The Global Market for Prescription Blood Modifier Drugs by Type
2004-2011
- Figure 9-2: Global Market for Prescription Blood Modifier Drugs by Type
2006
- Table 9-7: Blood Modifier Drugs in Development
- Table 9-8: Total Global Market for Prescription Blood Modifiers, Revenues
and Market Share by Supplier 2006
- Figure 9-4: Total Global Market for Prescription Blood Modifier Drugs,
Market Share by Leading Supplier 2006
CHAPTER TEN: PRESCRIPTION DIURETIC DRUGS
- Table 10-1: Marketed Diurectic Drugs
- Table 10-2: Total World Prescription Diuretic Drugs Market 2004-2011
- Figure 10-1: Total World Prescription Diuretic Drugs Market 2004-2011
- Table 10-3: Diuretic Drugs in Development
- Table 10-4: Total Global Market for Prescription Diuretic Drugs, Revenues
and Market Share by Supplier 2006
- Figure 10-2: Total Global Market for Prescription Diuretic Drugs, Market
Share by Leading Supplier 2006
CHAPTER ELEVEN: PRESCRIPTION OTHER CARDIOVASCULAR DRUGS
- Table 11-1: Marketed Other Cardiovascular Drugs
- Table 11-2: Total World Other Cardiovascular Drug Market 2004-2011
- Figure 11-1: Total World Other Cardiovascular Drug Market 2004-2011
- Table 11-3: Other Cardiovascular Drugs in Development
- Table 11-4: Total World Market for Other Cardiovascular Drugs Revenues and
Market Share by Supplier 2006
- Figure 11-5: Total World Market for Other Cardiovascular Drugs Market
Share by Leading Supplier 2006
CHAPTER TWELVE: WORLD MARKET SUMMARY
- Table 12-1: Total World Prescription Cardiovascular Drug Market 2004-2011
- Table 12-2 Total World Prescription Cardiovascular Drug Market by Product
Segment 2004-2011
- Figure 12-1: Total World Prescription Cardiovascular Drug Market by
Product Segment 2004-2011
- Figure 12-2: The World Market for Prescription Cardiovascular Drugs by
Product Segment Market Share 2006
- Table 12-3: World Market for Prescription Cardiovascular Drugs Revenues
and Segments of Participation by Major Areas of Participation 2006
- Figure 12-3: World Market for Prescription Cardiovascular Drugs Revenues
and Segments of Participation by Major Areas of Participation 2006
|
Related Report
|
View Cart
